...
首页> 外文期刊>Journal of Veterinary Internal Medicine >Characterization of the intestinal mucosal proteome in cats with inflammatory bowel disease and alimentary small cell lymphoma
【24h】

Characterization of the intestinal mucosal proteome in cats with inflammatory bowel disease and alimentary small cell lymphoma

机译:炎性肠疾病和消化小细胞淋巴瘤猫肠粘膜蛋白质组的特征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND:Current tests for diagnosis and differentiation of lymphoplasmacytic enteritis (LPE) and small cell lymphoma (SCL) in cats are expensive, invasive, and lack specificity. The identification of less invasive, more reliable biomarkers would facilitate diagnosis.OBJECTIVES:To characterize the mucosal proteome in endoscopically obtained, small intestinal tissue biopsy specimens. We hypothesized that differentially expressed proteins could be identified and serve as biomarker candidates for the differentiation of LPE and SCL in cats.ANIMALS:Six healthy control cats, 6 cats with LPE, and 8 cats with SCL.METHODS:The mucosal proteome was analyzed using 2-dimensional fluorescence difference gel electrophoresis (2D DIGE) and nanoflow liquid chromatography tandem mass spectrometry. For 5 proteins, results were verified by Western blot analysis.RESULTS:A total of 2349 spots were identified, of which 9 were differentially expressed with a ≥2-fold change between healthy cats and cats with LPE and SCL (.01? P ?.001). Eight of these 9 spots were also differentially expressed between cats with LPE and cats with SCL (P .001? P ?.04). However, Western blot analysis for malate dehydrogenase-1, malate dehydrogenase-2, apolipoprotein, annexin IV, and annexin V did not confirm significant differential protein expression for any of the 5 proteins assessed.CONCLUSIONS AND CLINICAL IMPORTANCE:Two-D DIGE did not identify potential biomarker candidates in the intestinal mucosa of cats with LPE and SCL. Future studies should focus on different techniques to identify biomarker candidates for cats with chronic enteropathies (CE).? 2020 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC. on behalf of the American College of Veterinary Internal Medicine.
机译:背景:猫淋巴结肠炎(LPE)和小细胞淋巴瘤(SCL)的诊断和分化的目前试验昂贵,侵入性,缺乏特异性。鉴定较少的侵袭性,更可靠的生物标志物将促进诊断。目的:在内窥镜获得的小肠组织活检标本中表征粘膜蛋白质组。我们假设可以鉴定差异表达的蛋白质,并作为生物标志物候选者,用于猫的LPE和SCL分化。六个健康对照猫,6只猫,LPE和8只猫。方法:使用粘膜蛋白质组二维荧光差凝胶电泳(2D DIGE)和纳米氟液相色谱串联质谱法。对于5个蛋白质,通过Western印迹分析验证结果。结果:鉴定了总共2349个斑点,其中9次差异表达了健康猫和猫与SCL和SCL(.01的猫之间的≥2倍。 P& 001)。这9个斑点中的八个也含有含有LPE和SCL的猫的猫之间的差异表达(p .001?<。04)。然而,对苹果醛脱氢酶-1,苹果酸脱氢酶-2,载脂蛋白,吞噬蛋白,吞噬蛋白和膜蛋白V的Western印迹分析未确认任何评估的5种蛋白质中的任何一个显着的差异蛋白表达。结论和临床重要性:双D Dige没有用LPE和SCL识别猫肠粘膜中的潜在的生物标志物候选。未来的研究应该专注于不同的技术,以鉴定患有慢性肠病(CE)的猫的生物标志物候选者。? 2020作者。 Wiley期刊LLC出版的兽医内科杂志。代表美国兽医内科学院。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号